Royal Bank Of Canada Trims Humana Inc. (HUM) Target Price to $217.00
Humana Inc. (NYSE:HUM) had its target price trimmed by Royal Bank Of Canada from $222.00 to $217.00 in a research note published on Thursday. The brokerage currently has a sector perform rating on the insurance provider’s stock.
Several other analysts also recently weighed in on the company. Jefferies Group upgraded Humana from a hold rating to a buy rating and raised their target price for the company from $158.89 to $210.00 in a research note on Monday, July 18th. JPMorgan Chase & Co. downgraded Humana from an overweight rating to a neutral rating and decreased their price target for the stock from $196.00 to $150.00 in a research note on Friday, July 8th. Argus reiterated a hold rating on shares of Humana in a research note on Tuesday, August 23rd. Wolfe Research assumed coverage on Humana in a research note on Tuesday, June 28th. They issued a market perform rating and a $244.00 price target for the company. Finally, Credit Suisse Group AG lifted their price target on Humana from $175.00 to $188.00 and gave the stock a neutral rating in a research note on Tuesday, August 16th. Seven investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Humana presently has an average rating of Buy and an average price target of $200.50.
Shares of Humana (NYSE:HUM) opened at 169.89 on Thursday. The firm’s 50-day moving average price is $175.73 and its 200 day moving average price is $175.51. Humana has a 1-year low of $150.00 and a 1-year high of $191.65. The stock has a market capitalization of $25.32 billion, a P/E ratio of 26.10 and a beta of 0.90.
Humana (NYSE:HUM) last announced its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.23 by $0.07. The company earned $14 billion during the quarter, compared to the consensus estimate of $13.59 billion. Humana had a return on equity of 11.11% and a net margin of 1.76%. The company’s revenue was up 2.0% on a year-over-year basis. During the same period last year, the firm earned $1.67 earnings per share. Analysts expect that Humana will post $9.24 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Thursday, October 13th will be issued a $0.29 dividend. The ex-dividend date of this dividend is Tuesday, October 11th. This represents a $1.16 annualized dividend and a dividend yield of 0.68%. Humana’s dividend payout ratio is currently 18.18%.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Daiwa SB Investments Ltd. boosted its position in Humana by 1.4% in the third quarter. Daiwa SB Investments Ltd. now owns 730 shares of the insurance provider’s stock valued at $129,000 after buying an additional 10 shares in the last quarter. Northwestern Mutual Investment Management Company LLC boosted its position in Humana by 0.4% in the second quarter. Northwestern Mutual Investment Management Company LLC now owns 5,684 shares of the insurance provider’s stock valued at $1,022,000 after buying an additional 22 shares in the last quarter. Fifth Third Bancorp boosted its position in Humana by 0.5% in the second quarter. Fifth Third Bancorp now owns 4,547 shares of the insurance provider’s stock valued at $818,000 after buying an additional 23 shares in the last quarter. Savant Capital LLC boosted its position in Humana by 1.3% in the second quarter. Savant Capital LLC now owns 2,380 shares of the insurance provider’s stock valued at $428,000 after buying an additional 30 shares in the last quarter. Finally, Cleararc Capital Inc. boosted its position in Humana by 0.9% in the second quarter. Cleararc Capital Inc. now owns 3,630 shares of the insurance provider’s stock valued at $653,000 after buying an additional 31 shares in the last quarter. 93.27% of the stock is currently owned by institutional investors.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.